A novel target for therapeutics against Staph infection
Friday, November 28, 2008 - 13:49
in Health & Medicine
Researchers at the Texas A and M Health Science Centre Institute of Biosciences and Technology, and the University of Edinburgh have uncovered how a bacterial pathogen interacts with the blood coagulation protein fibrinogen to cause methicillin-resistant Staphylococcus aureus (MRSA) infections, a finding that could aid in developing therapeutics against the potentially deadly disease. Their work appears 28 November in the open-access journal PLoS Pathogens...
Read the whole article on Science Centric
More from Science Centric
Related
- A novel target for therapeutics against Staph infectionFri, 28 Nov 2008, 9:24:06 EST
- Researchers map how staph infections alter immune systemTue, 14 Jul 2009, 0:42:57 EDT
- MRSA study suggests strategy shift needed to develop effective therapeuticsTue, 17 Mar 2009, 12:57:29 EDT
- More severe bone infections, health complications in children linked to MRSA, researchers findMon, 30 Jun 2008, 10:21:51 EDT
- Control of antibiotic-resistant bacteria in out-patient clinics and officesWed, 13 May 2009, 6:08:22 EDT